SynthesisBioMed research international2025
Advancements in Image-Based Analyses for Morphology and Staging of Colon Cancer: A Comprehensive Review.
Synthesis in BioMed research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Advancements in Image-Based Analyses for Morphology and Staging of Colon Cancer: A Comprehensive Review.BioMed research international · 2025Pooled it
- Attention-Enhanced ResNet-U-Net for Automated Colorectal Tumor Segmentation in CT Scans.Life (Basel, Switzerland) · 2026Article
- Article
- Diagnostic performance of photon-counting detector CT versus energy-integrating detector CT for colorectal polyp detection: a phantom study.Abdominal radiology (New York) · 2026Article
- Efficacy of Nano-Carbon Tracing Versus Indocyanine Green in Lymph Node Detection for Minimally Invasive Colorectal Resection.Medical science monitor : international medical journal of experimental and clinical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colon cancer remains a significant global health burden, accounting for approximately 10% of all cancer cases worldwide and ranking as the second leading cause of cancer-related mortality. Despite advances in treatment, the 5-year survival rate for late-stage colorectal cancer remains as low as 14%, whereas early detection can improve survival to over 90%. This review explores recent advancements in image-based analyses for the morphology and staging of colon cancer, focusing on key imaging modalities, including colonoscopy, computed tomography (CT), magnetic resonance imaging (MRI), endoscopic ultrasound (EUS), histopathological analysis, and the integration of artificial intelligence (AI) and machine learning (ML) algorithms. A systematic literature review was conducted using peer-reviewed studies from databases such as PubMed, Scopus, and IEEE Xplore. Selection criteria included studies published within the past decade that evaluated imaging techniques for colon cancer detection, staging, and treatment planning. AI and ML applications in colon cancer imaging were also examined, with an emphasis on their diagnostic accuracy, staging precision, and impact on clinical decision-making. Findings indicate that AI-assisted imaging techniques enhance lesion detection sensitivity (88%-94%) and improve staging accuracy compared to conventional radiology methods. AI models have also demonstrated superior predictive capabilities in treatment response and prognosis, with deep learning-based algorithms achieving over 90% accuracy in 5-year survival prediction. Despite these advancements, challenges persist, including interobserver variability, dataset biases, regulatory concerns, and the need for standardized AI validation protocols. Addressing these challenges requires interdisciplinary collaboration among clinicians, researchers, and policymakers to refine AI algorithms, develop standardized imaging protocols, and ensure equitable AI applications across diverse populations. By leveraging advancements in imaging and AI-driven analysis, colon cancer diagnosis and management can be significantly improved, ultimately enhancing early detection rates, treatment personalization, and patient survival outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.